FDA product code QVF: Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings

QVF is the FDA product code for simple point-of-care device to directly detect sars-cov-2 viral targets from clinical specimens in near-patient settings. It is a Class II device, regulated under 21 CFR 866.3982 and reviewed by the Microbiology panel. FDA has cleared 10 510(k) submissions under QVF, 10 in the last five years, from 10 different applicants. The average 510(k) review took 199 days (median 182); 218 days on average over the last three years. 1 De Novo request was granted under it.

Definition

A simple point-of-care device to detect SARS-CoV-2 viral targets directly from clinical specimens in near-patient settings is an in vitro diagnostic device for the direct detection of SARS-CoV-2 in clinical specimens and is intended as an aid in the diagnosis of SARS-CoV-2 infections COVID-19). The device is simple to use and does not involve sample manipulation, transportation of the sample to another functional area (e.g., a central laboratory or other specialized area), or measurement of reagents or analytes that could be affected by conditions such as sample turbidity or cell lysis. The design and procedures of the device are appropriate for use by healthcare professionals in near-patient settings outside a centralized laboratory

Classification

FieldValue
Device nameSimple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings
Device classClass II
Regulation21 CFR 866.3982
Review panelMI — Microbiology
Medical specialtyMicrobiology
Premarket route510(k)

510(k) clearances per year for QVF

YearClearancesAvg. review days
2023126
20243285
20253165
20263203

Compare with all 510(k) review times · Search every QVF clearance

Top QVF applicants

ApplicantClearancesLatest
BD Diagnostic Solutions / Becton, Dickinson & Company12026-10-27
Ortho-Clinical Diagnostics, Inc. (QuidelOrtho)12026-09-04
CorDx, Inc.12026-06-01
Guangzhou Wondfo Biotech Co., Ltd.12025-10-22
Becton, Dickinson and Company12025-06-16

5 more applicants have QVF clearances. See the full list in Caduvo.

Most recent QVF clearances

510(k)ApplicantDeviceDecision dateReview days
K261379BD Diagnostic Solutions / Becton, Dickinson & CompanyBD Veritor System for SARS-CoV-22026-10-27183
K254264Ortho-Clinical Diagnostics, Inc. (QuidelOrtho)Sofia 2 SARS Antigen+ FIA; Sofia 2 Lyme FIA2026-09-04248
K253882CorDx, Inc.CorDx Tyfast COVID-19 Ag Rapid Test Rx2026-06-01179
K251289Guangzhou Wondfo Biotech Co., Ltd.WELLlife COVID-19 Antigen Test Rx2025-10-22180
K243872Becton, Dickinson and CompanyBD Veritor System for SARS-CoV-22025-06-16181

Recalls for QVF devices

FDA recall records list no recalls for product code QVF.

Frequently asked questions

What is FDA product code QVF?

QVF is the FDA product code for simple point-of-care device to directly detect sars-cov-2 viral targets from clinical specimens in near-patient settings. It is a Class II device, regulated under 21 CFR 866.3982 and reviewed by the Microbiology panel.

What device class is QVF?

Class II, regulation 21 CFR 866.3982. Typical premarket route: 510(k).

How long does a 510(k) take for product code QVF?

Across 10 cleared submissions the average was 199 days from receipt to decision (median 182).

Which companies have the most QVF clearances?

BD Diagnostic Solutions / Becton, Dickinson & Company (1); Ortho-Clinical Diagnostics, Inc. (QuidelOrtho) (1); CorDx, Inc. (1); Guangzhou Wondfo Biotech Co., Ltd. (1); Becton, Dickinson and Company (1).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Microbiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times